| Ulcerative Colitis |
1 |
1 |
| Thromboembolism |
0 |
0.95 |
| Clinical Research |
0 |
0.9 |
| Biologic Therapy |
0 |
0.59 |
| Inflammatory Bowel Disease |
0 |
0.49 |
| Pulmonary Embolism |
0 |
0.6 |
| Lipids Management |
0 |
0.5 |
| Hemoglobin |
0 |
0.39 |
| Anti-Tumor Necrosis Factor (Anti-TNF) |
0 |
0.35 |
| Colitis |
0 |
0.26 |
| Thrombosis |
0 |
0.26 |
| Rheumatoid Arthritis |
0 |
0.23 |
| Tumor Necrosis Factor-Alpha |
0 |
0.22 |
| Arthralgia |
0 |
0.18 |
| Crohn Disease |
0 |
0.16 |
| Electronic Health Record (EHR) and Healthcare Technology |
0 |
0.16 |
| Pain Management |
0 |
0.16 |
| Vaccines |
0 |
0.16 |
| Abdomen |
0 |
0.13 |
| Anemia |
0 |
0.13 |
| Arthritis |
0 |
0.13 |
| Corticosteroids |
0 |
0.13 |
| Embolism |
0 |
0.13 |
| Immunization |
0 |
0.13 |
| Medical Innovations |
0 |
0.13 |
| Pain |
0 |
0.13 |
| Steroids |
0 |
0.13 |
| Surgery |
0 |
0.13 |
| Tumor |
0 |
0.13 |
| Venous Thromboembolism (VTE) |
0 |
0.99 |